ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

INM Company Profile and Key Details

NASDAQ : INM

InMed Pharmaceuticals Inc.

$2.08

-0.005-0.24%

At Close 4:00 PM

63.64

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

INM Stock Price Chart

Stock Price Today

InMed Pharmaceuticals Inc. (INM) stock declined over -0.24%, trading at $2.08 on NASDAQ, down from the previous close of $2.08. The stock opened at $2.08, fluctuating between $2.06 and $2.14 in the recent session.

Stock Snapshot

2.08

Prev. Close

2.08

Open

2.5M

Market Cap

1.21M

Number of Shares

2.06

Day Low

2.143

Day High

-0.17

P/E Ratio

98.44%

Free Float in %

-12.42

EPS (TTM)

1.6

Book Value

-0.82

Cash Flow per Share

37.12K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2025	2.08	2.14	2.06	2.08	37.17K
Apr 01, 2025	2.03	2.11	1.99	2.08	20.4K
Mar 31, 2025	2.19	2.19	2.01	2.07	30.29K
Mar 28, 2025	2.66	2.66	2.06	2.06	36.83K
Mar 27, 2025	2.64	2.64	2.59	2.64	5.5K
Mar 26, 2025	2.74	2.76	2.65	2.65	4.3K
Mar 25, 2025	2.85	2.86	2.72	2.75	9.81K
Mar 24, 2025	2.79	2.85	2.78	2.85	3.8K
Mar 21, 2025	2.77	2.88	2.77	2.78	4.1K
Mar 20, 2025	2.83	2.83	2.78	2.78	2.82K
Mar 19, 2025	2.75	2.81	2.73	2.78	16.92K
Mar 18, 2025	2.72	2.88	2.65	2.88	21.91K
Mar 17, 2025	2.90	2.90	2.73	2.74	24.2K
Mar 14, 2025	2.87	2.87	2.70	2.82	2.81K
Mar 13, 2025	2.68	2.89	2.60	2.69	4.91K
Mar 12, 2025	2.60	2.77	2.58	2.67	16.72K
Mar 11, 2025	2.53	2.66	2.53	2.64	20.63K
Mar 10, 2025	2.68	2.68	2.53	2.53	37.03K
Mar 07, 2025	2.71	2.80	2.65	2.73	17.82K
Mar 06, 2025	2.71	2.80	2.56	2.76	11.9K

Contact Details

Vancouver, BC V6C 1B4

Canada

Website: https://www.inmedpharma.comContact: 604 669 7207

About Company

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosynthesis-based manufacturing approach, for synthesizing pharmaceutical-grade cannabinoids. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.

Frequently Asked Questions

What is the current InMed Pharmaceuticals Inc. (INM) stock price?

InMed Pharmaceuticals Inc. (NASDAQ: INM) stock price is $2.08 in the last trading session. During the trading session, INM stock reached the peak price of $2.14 while $2.06 was the lowest point it dropped to. The percentage change in INM stock occurred in the recent session was -0.24% while the dollar amount for the price change in INM stock was -$0.01.

INM's industry and sector of operation?

The NASDAQ listed INM is part of Biotechnology industry that operates in the broader Healthcare sector. InMed Pharmaceuticals Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of INM?

Dr. Sazzad Hossain M.Sc., Ph.D.
Co-Founder
Mr. Michael Woudenberg P.Eng.
Chief Operating Officer
Dr. Shane A. Johnson Ph.D.
Senior Vice President & GM of BayMedica
Ms. Sarah Li C.P.A., CGA
Vice President of Accounting & Controller
Ms. Brenda Edwards C.M.A., C.P.A.
Chief Accounting Officer
Dr. Ado Muhammad
Senior Consultant of Medical Affairs
Mr. Jonathan R. Tegge
Interim Chief Financial Officer
Ms. Sarah Li
Vice President of Accounting, Controller & Principal Accounting Officer
Dr. Eric Chih-Hsien Hsu
Senior Vice President of Preclinical R&D
Ms. Sarah Li CPA, CGA
Vice President of Accounting & Controller
Colin Clancy
Senior Director of Investor Relations
Ms. Alexandra Diane-Janet Mancini M.Sc.
Senior Vice President of Clinical & Regulatory Affairs
Mr. Jerry P. Griffin
Vice President of Sales & Marketing
Mr. Eric A. Adams B.S. Chem., M.I.B.
Pres, Chief Executive Officer & Director

How INM did perform over past 52-week?

INM's closing price is 4.27% higher than its 52-week low of $1.99 where as its distance from 52-week high of $15.70 is -86.78%.

How many employees does INM have?

Number of INM employees currently stands at 13.

Link for INM official website?

Official Website of INM is: https://www.inmedpharma.com

How do I contact INM?

INM could be contacted at phone 604 669 7207 and can also be accessed through its website. INM operates from 815 West Hastings Street, Vancouver, BC V6C 1B4, Canada.

How many shares of INM are traded daily?

INM stock volume for the day was 37.12K shares. The average number of INM shares traded daily for last 3 months was 495.08K.

What is the market cap of INM currently?

The market value of INM currently stands at $2.50M with its latest stock price at $2.08 and 1.21M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

INM Stock Price Chart

Stock Price Today

Stock Snapshot

2.08

Prev. Close

2.08

Open

2.5M

Market Cap

1.21M

Number of Shares

2.06

Day Low

2.143

Day High

-0.17

P/E Ratio

98.44%

Free Float in %

-12.42

EPS (TTM)

1.6

Book Value

-0.82

Cash Flow per Share

37.12K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2025	2.08	2.14	2.06	2.08	37.17K
Apr 01, 2025	2.03	2.11	1.99	2.08	20.4K
Mar 31, 2025	2.19	2.19	2.01	2.07	30.29K
Mar 28, 2025	2.66	2.66	2.06	2.06	36.83K
Mar 27, 2025	2.64	2.64	2.59	2.64	5.5K
Mar 26, 2025	2.74	2.76	2.65	2.65	4.3K
Mar 25, 2025	2.85	2.86	2.72	2.75	9.81K
Mar 24, 2025	2.79	2.85	2.78	2.85	3.8K
Mar 21, 2025	2.77	2.88	2.77	2.78	4.1K
Mar 20, 2025	2.83	2.83	2.78	2.78	2.82K
Mar 19, 2025	2.75	2.81	2.73	2.78	16.92K
Mar 18, 2025	2.72	2.88	2.65	2.88	21.91K
Mar 17, 2025	2.90	2.90	2.73	2.74	24.2K
Mar 14, 2025	2.87	2.87	2.70	2.82	2.81K
Mar 13, 2025	2.68	2.89	2.60	2.69	4.91K
Mar 12, 2025	2.60	2.77	2.58	2.67	16.72K
Mar 11, 2025	2.53	2.66	2.53	2.64	20.63K
Mar 10, 2025	2.68	2.68	2.53	2.53	37.03K
Mar 07, 2025	2.71	2.80	2.65	2.73	17.82K
Mar 06, 2025	2.71	2.80	2.56	2.76	11.9K

Contact Details

Vancouver, BC V6C 1B4

Canada

Website: https://www.inmedpharma.comContact: 604 669 7207

About Company

Frequently Asked Questions

What is the current InMed Pharmaceuticals Inc. (INM) stock price?

INM's industry and sector of operation?

Who are the executives of INM?

How INM did perform over past 52-week?

INM's closing price is 4.27% higher than its 52-week low of $1.99 where as its distance from 52-week high of $15.70 is -86.78%.

How many employees does INM have?

Number of INM employees currently stands at 13.

Link for INM official website?

Official Website of INM is: https://www.inmedpharma.com

How do I contact INM?

INM could be contacted at phone 604 669 7207 and can also be accessed through its website. INM operates from 815 West Hastings Street, Vancouver, BC V6C 1B4, Canada.

How many shares of INM are traded daily?

INM stock volume for the day was 37.12K shares. The average number of INM shares traded daily for last 3 months was 495.08K.

What is the market cap of INM currently?

The market value of INM currently stands at $2.50M with its latest stock price at $2.08 and 1.21M of its shares outstanding.

Employees	13
Beta	0.68
Sales or Revenue	$4.60M
5Y Sales Change%	0%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Biotechnology

Employees	13
Beta	0.68
Sales or Revenue	$4.60M
5Y Sales Change%	0%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Biotechnology

INM Company Profile and Key Details

InMed Pharmaceuticals Inc.

INM Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions

INM Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions